Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulær blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Norge -
norsk -
Statens legemiddelverk
dipentum 500 mg
atnahs pharma netherlands b.v. - olsalazinnatrium - tablett - 500 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Norge -
norsk -
Statens legemiddelverk
sugammadex baxter 100 mg/ ml
baxter holding b.v. - sugammadeksnatrium - injeksjonsvæske, oppløsning - 100 mg/ ml